Tandem Diabetes Care's GAAP loss for 3 months of 2022 was $14.715 million, up 2.92 times from $5.044 million in the previous year. Revenue increased 24.7% to $175.907 million from $141.037 million a year earlier.

Tandem Diabetes Care's GAAP net income for 2021 was $15.566 million, compared to a loss of $34.382 million in the previous year. Revenue increased 40.9% to $702.799 million from $498.83 million a year earlier.

Tandem Diabetes Care's GAAP net income for 9M 2021 was $4.758 million, against a loss of $51.382 million in the previous year. Revenue increased 49% to $492.803 million from $330.765 million a year earlier.

Tandem Diabetes Care's GAAP loss for six months of 2021 was $1.036 million, down 40.5 times from $41.974 million in the prior year. Revenue increased 51.2% to $313.176 million compared to $207.162 million a year earlier.